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ABSTRACT
The genomes of gut Bacteroidales contain numer-
ous invertible regions, many of which contain pro-
moters that dictate phase-variable synthesis of sur-
face molecules such as polysaccharides, fimbriae,
and outer surface proteins. Here, we characterize
a different type of phase-variable system of Bac-
teroides fragilis, a Type I restriction modification sys-
tem (R-M). We show that reversible DNA inversions
within this R-M locus leads to the generation of eight
specificity proteins with distinct recognition sites. In
vitro grown bacteria have a different proportion of
specificity gene combinations at the expression lo-
cus than bacteria isolated from the mammalian gut.
By creating mutants, each able to produce only one
specificity protein from this region, we identified the
R-M recognition sites of four of these S-proteins us-
ing SMRT sequencing. Transcriptome analysis re-
vealed that the locked specificity mutants, whether
grown in vitro or isolated from the mammalian gut,
have distinct transcriptional profiles, likely creat-
ing different phenotypes, one of which was con-
firmed. Genomic analyses of diverse strains of Bac-
teroidetes from both host-associated and environ-
mental sources reveal the ubiquity of phase-variable
R-M systems in this phylum.
INTRODUCTION
The human gut is colonized with numerous species and
strains of microbes. Bacteroides is one of the most abundant
bacterial genera in the human gut, with >20 human gut
species. These Gram-negative bacteria have many unique
properties, including the ability to invert an extensive num-
ber of DNA regions throughout their genomes. These DNA
inversions include the promoter regions of the numerous
capsular polysaccharide biosynthesis loci (1–3), the pro-
moter for an extracellular polysaccharide (EPS) (4), pro-
moters for putative fimbriae regions (5–8) and promoters
for S-layer proteins and other outer surface proteins (9–
12). Site-specific recombinases of either the serine or tyro-
sine families mediate these distinct DNA inversions (5,8,9).
DNA inversions in the gut Bacteroidales have been best
studied in B. fragilis NCTC 9343. The complete genome se-
quence of B. fragilis NCTC 9343 revealed a total of 28 in-
vertible regions throughout this organism’s genome (13). A
few of these invertible regions do not contain promoters, but
rather involve the inversion of full or partial genes (13). One
region subject to DNA inversions identified by genome se-
quencing contains genes encoding specificity proteins for a
Type I restriction-modification system (R-M) (13). Genetic
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analyses of this region, the methylated sites, and the result-
ing phenotypes were not previously performed.
Type I R-M systems are pentameric protein complexes
comprised of a specificity protein that dictates the DNA
recognition sequence, two methyltransferase subunits, and
two restriction enzyme subunits (reviewed (14)). The speci-
ficity proteins are composed of a modular architecture with
two DNA binding domains, one in each half of the pro-
tein, known as target recognition domains (TRD). Each
TRD recognizes a distinct DNA sequence. When the com-
plex binds DNA, at the target sequence, it either methylates
it or restricts it. The methylation occurs typically at an ade-
nine residue within the recognition sequence creating N6-
methyladenine (m6A) of hemimethylated DNA. Restriction
occurs on unmethylated DNA, usually at a site distant from
the recognition sequence. Each half of the specificity protein
recognizes a distinct 3-4 bp sequence separated by approxi-
mately 5-7 unspecified nucleotides, making the recognition
sequence in most cases non-palindromic.
Type I R-M is a ubiquitous defensive system to com-
bat invasive foreign DNA. Bacteriophages have evolved nu-
merous mechanisms to circumvent restriction by R-M sys-
tems, including encoding anti-restriction proteins in their
genomes and limiting the number of recognition sites (15).
Bacteria in turn continue to evolve systems to counter-
act phage escape. One such mechanism is to change the
site where foreign DNA is restricted by changing the R-M
recognition site. The modular nature of Type I specificity
proteins allows the protein to change its recognition site by
varying the N- and C-terminal TRD. Such domain shuf-
fling and rearrangements of specificity-encoding genes has
been demonstrated in numerous bacteria, and, in a few or-
ganisms, the shuffling is due to site-specific DNA inversions
(11,16–19).
The extensive number of invertible regions in the
genomes of gut Bacteroidales suggests that these DNA in-
versions contribute to fitness, likely by a bet-hedging strat-
egy where distinct bacterial phenotypes arise in a popula-
tion, leading to intra-strain diversity. In this study, we pro-
vide the first characterization of a phase-variable Type I re-
striction modification system of the gut Bacteroidales. We
show that reversible DNA inversions at four different in-
verted repeats within a single R-M locus leads to the genera-
tion of eight distinct specificity genes all of which are present
at the expression locus in a population of bacteria resulting
in extensive methylome variation within a population. By
creating a series of mutants, each of which can synthesize
only one distinct specificity protein, we characterized the R-
M recognition sites using SMRT sequencing. We also char-
acterized the transcriptome of each of the locked specificity
mutants from both in vitro and in vivo grown bacteria, and
demonstrated that phase-variable R-M systems are ubiqui-
tous in diverse members of the Bacteroidetes phylum.
MATERIALS AND METHODS
All primers used in this study are listed in Supplementary
Table S4.
Bacterial strains and growth conditions
B. fragilis NCTC 9343 and isogenic mutants were grown in
supplemented basal medium (20) or on supplemented brain
heart infusion (BHIS) plates. Erythromycin was added
where appropriate (5 g/ml). Escherichia coli strains were
grown in L broth or L agar plates with antibiotics added
where appropriate; ampicillin 100 g/ml, trimethoprim 100
g/ml, kanamycin 50 g/ml.
Expression analysis of specificity gene combinations
To determine if each of the six specificity half-genes could
be present at the expression locus, primers were designed
that bind the end of each half gene and were coupled in
PCR with a forward primer at the end of the methylase en-
coding gene (BF9343 1756) (Figure 1). To analyze the rel-
ative percentage of expression of each of the eight hybrid
specificity genes from a bacterial population, RT-qPCR was
performed with primers that amplify across the junctions
of each of the eight different specificity gene combinations
(Supplementary Table S4). Wild type (WT) bacteria were
grown to OD600 ∼0.7, and RNA was isolated using Trizol.
qRT-PCR was performed using the KAPA SYBR FAST kit
(One step KK4651, KAPA Biosystems). Results were nor-
malized to the housekeeping gene rpsL (BF9343 3902). The
Ct method was employed for the specificity fold change
tests. For the quantification of the specificities, standard
curves of each locked-ON mutants were generated. Samples
were normalized to the same Ct number, and each speci-
ficity primer was normalized according to its primer effi-
ciency compared to the rpsL primer efficiency. Ct levels of
the four specificities were compared to get relative percent-
age of each product.
Creation of locked specificity gene mutants and complement-
ing plasmids
To create mutants locked with different specificity gene
combinations at the expression site, the region was oriented
to place each specific pattern in the expression locus in sil-
ico, and then primers were designed to delete the remain-
ing specificity genes. DNA upstream and downstream of
the region to be deleted were PCR amplified, and the prod-
ucts were digested and cloned by three-way ligation into
E. coli DH5 pNJR6 (21). The resulting plasmids were
conjugally transferred into wild-type B. fragilis 9343 using
helper plasmid R751 (22), and cointegrates were selected by
erythromycin resistance. Double cross-out resolvants were
screened by PCR to identify mutants.
Genes used for complementation studies were PCR am-
plified and cloned into expression vector pFD340 (23). Re-
sulting plasmids were verified by sequencing and trans-
ferred to B. fragilis by conjugal mating using helper plasmid
RK231.
RNA isolation and RT-qPCR from colonic contents
For RNAseq and RT-qPCR analyzes from bacteria from
the mouse colon, germ-free Swiss Webster mice (5-7-
weeks) of both sexes were mono-colonized with WT B.
fragilis or mutants for 10 days. Stool and cecal contents
were harvested. These contents were suspended in 1 ml
Trizol reagent (ThermoFisher Scientific), transferred to
2 mL FastPrep tubes (MP Biomedicals) containing 0.1 mm
Zirconia/Silica beads (BioSpec Products) and bead beaten
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Biomedicals). After addition of 200 l chloroform, each
sample tube was mixed thoroughly by inversion, incubated
for 3 min at room temperature, and centrifuged for 15 min
at 4oC. The aqueous phase was mixed with an equal vol-
ume of 100% ethanol, transferred to a Direct-zol spin plate
(Zymo Research), and RNA was extracted according the
the Direct-zol protocol (Zymo Research).
Samples were treated by TURBO DNA-free kit (Thermo
scientific) in accordance with the manufacturer’s instruc-
tions. cDNA was synthesized using Verso cDNA synthesis
kit (Thermo scientific). RT-qPCR was performed with 20–
50 ng of cDNA per well (in a 96-well plate), using the same
conditions stated in ‘Expression analysis of specificity gene
combinations’.
RNAtag-Seq
Illumina cDNA libraries were generated using a modified
version of the RNAtag-seq protocol (24). Briefly, 500 ng–
1 g of total RNA was fragmented, depleted of genomic
DNA, dephosphorylated, and ligated to DNA adapters car-
rying 5′-AN(8)-3′ barcodes of known sequence with a 5′
phosphate and a 3′ blocking group. Barcoded RNAs were
pooled and depleted of rRNA using the RiboZero rRNA
depletion kit (Epicentre). Pools of barcoded RNAs were
converted to Illumina cDNA libraries in two main steps:
(i) reverse transcription of the RNA using a primer de-
signed to the constant region of the barcoded adaptor with
the addition of an adapter to the 3′ end of the cDNA by
template switching using SMARTScribe (Clontech) as de-
scribed (25); (ii) PCR amplification using primers whose 5′
ends target the constant regions of the 3′ or 5′ adaptors and
whose 3′ ends contain the full Illumina P5 or P7 sequences.
cDNA libraries were sequenced on the Illumina [Nextseq
2500] platform to generate paired end reads.
Sequencing reads from each sample in a pool were de-
multiplexed based on their associated barcode sequence us-
ing custom scripts. Up to one mismatch in the barcode was
allowed provided it did not make assignment of the read
to a different barcode possible. Barcode sequences were re-
moved from the first read as were terminal G’s from the sec-
ond read that may have been added by SMARTScribe dur-
ing template switching.
Reads were aligned to the B. fragilis NCTC 9343
genome (RefSeq accessions NC 003228.3 (chromosome)
and NC 006873.1 (plasmid)) using BWA (26) and read
counts were assigned to genes and other genomic features
using custom scripts. Differential expression analysis was
conducted with DESeq2 (27) and edgeR (28). The in vivo
and in vitro heatmaps of B. fragilis NCTC 9343 genes found
to be differentially expressed (Figure 5) were created using
the R package pheatmap (v. 1.0.12 . https://cran.r-project.
org/package=pheatmap).
Competitive colonization assays in gnotobiotic mice
Mouse studies were approved by the Harvard Medical Area
Standing Committee on Animals, or by the Institutional
Animal Care and Use Committee (IACUC), Brigham &
Women’s Hospital or the Technion’s Institutional Animal
Care and Use Committee, in accordance with the NRC
guide and comply with all relevant ethical regulations for
animal testing and research. Swiss-Webster germ-free mice
(4–6 weeks old) were obtained from the Geva-Zatorsky lab
germ-free colony at the Technion, or the Harvard Diges-
tive Diseases Center gnotobiotic facility. Mice were kept
in individually ventilated cages (ISOcage N System, Tec-
niplast, Buguggiate, Italy or Optimice) with a maximum
of five mice per cage. Both males and females were used
and housed separately. Each of the four locked-ON mutants
were grown to an OD600 of 0.4, and mixed at a 1:1:1:1 ra-
tio (actual ratio shown in Figure 3A), and then were either
diluted 1:15 in fresh medium and grown to an OD600 of 0.4
and plated for quantification for the in vitro competition,
or gavaged into germ-free mice. The feces were collected af-
ter 18 h and 10 days, diluted in PBS and plated for single
colonies. Strains were differentiated and quantified by PCR.
Each reaction was performed with four sets of primers pro-
ducing different sized amplicons, each corresponding to one
of the four specificities. Only samples that showed a single
PCR product were counted. A one sample t-test on arcsine-
transformed values was used to determine if the ratios of
strains in the inoculum differed from those in feces.
Pac-Bio sequencing and methylation pattern detection
Genomic DNA from WT and the four locked speci-
ficity gene mutants were sequenced. SMRTbell template
libraries were prepared as previously described (29,30).
Briefly, genomic DNA samples were sheared to an aver-
age size of ∼10–20 kb using the G-tubes protocol (Co-
varis; Woburn, MA, USA), additionally purified using a
PowerClean DNA Clean up kit (MoBio laboratories, Inc.,
Carsbad, CA, USA), end repaired, and ligated to hairpin
adapters. Incompletely formed SMRTbell templates were
digested with a combination of Exonuclease III (New Eng-
land Biolabs; Ipswich, MA, USA) and Exonuclease VII
(Affymetrix; Cleveland, OH, USA). Genomic DNA frag-
ments and SMRTbell library qualification and quantifi-
cation were performed using a Qubit fluorimeter (Invit-
rogen, Eugene, OR, USA) and 2100 Bioanalizer (Agilent
Technology, Santa Clara, CA, USA). SMRT sequencing
was carried out on the PacBio RSII (Pacific Biosciences;
Menlo Park, CA, USA) using standard protocols for large
insert SMRTbell libraries. Sequencing reads were pro-
cessed, mapped and assembled on the Pacific Biosciences’
SMRT Analysis pipeline (http://www.pacbiodevnet.com/
SMRT-Analysis/Software/SMRT-Pipe) using the HGAP
protocol (31).
Interpulse durations (IPDs) were measured as previously
described (32) and processed as described (29) for all pulses
aligned to each position in the reference sequence. To
identify modified positions, we used Pacific Biosciences’
SMRTPortal analysis platform, v. 1.3.1, which uses an
in silico kinetic reference, and a t-test based kinetic score
detection of modified base positions (details are available
at https://www.pacb.com/wp-content/uploads/2015/09/
WP Detecting DNA Base Modifications Using SMRT
Sequencing.pdf. MTase target sequence motifs were iden-
tified by selecting the top one thousand kinetic hits and
subjecting a ±20 base window around the detected base to
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for each motif in a genome, a kinetic score threshold
was chosen such that 1% of the detected signals were not
assigned to any MTase recognition motifs.
Methylation site frequency analysis
Enumeration and localization of the four methylation pat-
terns was performed using fuzznuc from the EMBOSS suite
of programs, and by custom Perl scripts using regular ex-
pressions. Each molecule (the B. fragilis NCTC 9343 chro-
mosome (accession no. NC 003228), the pBF9343 resident
plasmid (NC 006873)) was searched on both strands, allow-
ing for overlapping sites.
PCR-digestion of polysaccharide promoter regions
A previously described PCR-digestion technique was used
to quantify the percentage of B. fragilis bacteria with the
seven invertible polysaccharide (PS) biosynthesis loci pro-
moters oriented ON or OFF (1,34). Chromosomal DNA
was isolated from all specificity gene locked-ON mutants
and PCRs were performed using primers that annealed out-
side the IRs flanking each invertible PS promoter region.
Each PS promoter region PCR product was digested with
a restriction enzyme that cleaves asymmetrically (34) result-
ing in four differently sized fragments, two from a promoter
in the ON orientation and two from a promoter in the OFF
orientation.
Fluorescence microscopy
Bacteria were grown in basal media to OD600 of 0.6,
washed, and incubated with a rabbit antiserum specific
to PSB (1). Cells were washed and mixed with Alexa
Fluor 488-labeled goat anti-rabbit IgG antibody (Molecu-
lar Probes). Bacteria were washed and imaged using an Ax-
ioplan 2 imaging system (Zeiss) at 600×.
Flow cytometry
B. fragilis was grown to OD600 = 0.5. 10 l of the sam-
ples were added to 1 ml of PBS, and was washed twice with
FACS buffer (2% fetal bovine serum, 1 mM EDTA, 0.1%
sodium azide in PBS). PSB-specific antiserum was added
and the sample was incubated for 1 h at 4◦C. The sample
was washed again twice with FACS buffer and incubated
with Alexa Fluor 488-labeled goat anti-rabbit IgG antibody
(Molecular Probes) for 1 h at 4◦C in the dark. The cells were
washed with PBS and fixed with 4% of paraformaldehyde in
the dark for 1h, following analysis by flow cytometry. Data
were collected on LSR Fortessa (BD Biosciences) and ana-
lyzed with the ‘Kaluza’ software (Beckman Coulter). Bac-
teria cells positive for PSB were gated.
Prevalence of putative phase-variable Type I restriction-
modification systems in Bacteroidetes
Our locally maintained collection of bacterial genomic se-
quences includes 3528 genomes identified by the National
Center for Biotechnology Information as belonging to
the phylum Bacteroidetes and that also include depositor-
supplied or NCBI-generated protein sequence information.
This collection of proteomes was searched using the hmm-
search program (v. 3.2.1) and the profile hidden Markov
model PF01420.18 (Pfam v. 31) to detect protein sequences
potentially encoding a Type I restriction modification DNA
specificity domain. To be further considered, the bit score
of each initial match had to equal or exceed the gathering
threshold score (20.70) included in the HMM model. This
initial survey detected one or more such matches encoded
by each of 2329 genomes. Further parsing of these initial
scan results required that each retained genome had two
or more such matches on the same contig (1126 genomes)
and that these matches be within 10 kb of each other (955
genomes). Finally, the match data were further parsed by
comparing the amino acid sizes of the putative restriction
modification DNA specificity proteins, requiring that the
largest protein in the retained loci be at least 40% larger
than one or more of the smaller proteins in the same loci
(686 genomes).
This retained set (Supplementary Table S3) is for illus-
trative purposes, and likely does not reflect the true count
of such loci in Bacteroidetes for several reasons. Examples
include: (i) the draft nature of most of the genome assem-
blies likely resulted in proteins containing the motif which
were in reality in close proximity to one another to be con-
tained on different contigs, thus excluding them from fur-
ther consideration, (ii) the smaller, N-terminal alternative
specificity domain regions must have been translated as an
open reading frame by the depositor to even appear in the
genome’s proteome for possible detection, (3) the PFam
HMM model was constructed using a seed alignment of
31 protein domains, none of which originated from a Bac-
teroidetes species, thus using the gathering threshold bit
score cut-off might be less applicable to Bacteroidetes pro-
teins, (4) both the ≤10 kb separation defining the necessary
proximity of these proteins to one another and the require-
ment that one or more of the smaller protein sequences in
a loci be no >60% of the size of the largest protein in the
same loci are arbitrary cut-off choices, and may erroneously
include or exclude such loci.
MinION library preparation and sequencing
The specificity region of BF9343 1757–1760 was amplified
by PCR from a population of bacteria grown in vitro and
in vivo from fecal content as described above. The primers
annealed outside the invertible region (Supplementary Ta-
ble S4). The amplicons were purified by Wizard SV Gel and
PCR Clean-Up System (Promega), and measured by nan-
odrop.
DNA quantity was measured again using Qubit fluo-
rometry (Thermo Fisher Scientific, Waltham, MA, USA).
Nanopore sequencing libraries were prepared from 200
fmol purified amplicons using Ligation Sequencing Kit
1D (SQK-LSK109) and PCR-free Native Barcoding Ex-
pansion Kit (EXP-NBD104) (Oxford Nanopore Tech-
nologies, Oxford, England). The barcoded libraries were
loaded and sequenced on the MinION device controlled by
MinKNOW software (v.19.12.5) using MinION flow cells
(FLO-MIN106D R9.4.1, Oxford Nanopore Technologies,
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were base called and demultiplexed by Guppy Basecalling
Software (v. 3.3.3+fa743a6).
MinION data analysis
Adapters and barcodes sequences were removed from
the reads using Porechop (v0.2.4, available from https://
github.com/rrwick/Porechop). Reads were oriented using
the ‘Preparing Reads for Stranded Mapping’ protocol (Ec-
cles, D.A. (2019). Protocols.io, Vol. 2019, pp. Protocol).
We aligned the reads to the PCR forward primer using
LASTAL (v.1060) (35), and then reverse-complemented the
reverse-oriented reads. The reads were combined to an all
forward oriented file and cropped to the first 1300 bases us-
ing Trimmomatic (v.0.39) (36). The reads were then split ac-
cording to their alignment to the 1757-57 or 1757-60 5” half
sequences using LASTAL. Reads were mapped to the full
sequences with Minimap2 (v.2.17-r941) (37) using the –
for-only and asm20 options. Mapped read counts were ex-
tracted from the Minimap2 SAM output using SAMtools
(v.1.7) (38)
MinION sequence data has been deposited in the NCBI
sequence read archive (SRA) under the BioProject acces-
sion number: PRJNA648829.
RESULTS
A phase-variable Type I restriction modification system of B.
fragilis
A genetic region encoding a Type I R-M system of B.
fragilis NCTC 9343 includes genes BF9343 1753 through
BF9343 1760 (Figure 1A). BF9343 1753 encodes a puta-
tive XRE family transcriptional regulator, BF9343 1754 en-
codes a Type I restriction enzyme (hsdR), BF9343 1755 en-
codes a protein with endonuclease motifs, BF9343 1756 en-
codes a Type I methyltransferase (hsdM), and the next four
genes or partial genes, BF9343 1757 through BF9343 1760,
encode six distinct modules (N-terminal or C-terminal half)
of Type I specificity proteins (Figure 1A, B). The genome
sequence revealed the presence of four distinct inverted re-
peats (IRs) of between 16 and 47 bp within this specificity
genes region (Figure 1B dashed lines, S1b) (13). The en-
tire region, beginning with BF9343 1753 through to the
specificity gene BF9343 1757, is a predicted operon with
very little intergenic DNA (32 bp or less between genes).
Only one specificity gene is actively transcribed - the gene
in the expression locus just downstream of hdsM (Figure
1B, C, outlined in black). The other genes in the locus ei-
ther lack the 5′ end of the gene or are not downstream
of a promoter (Figure 1B). Based on the genetic architec-
ture, there are two different half-genes that could encode
the N-terminal portion of the specificity protein (shown in
blue and yellow, Figure 1A, B) and four different half-genes
that could invert into the expression locus and comprise the
C-terminal portion of the specificity protein (green, pink,
gray, and red, Figure 1A,B). An inversion event of IR-A,
(Figure 1B, dashed lines), would change the 5′ end of the
gene, for example, from blue (BF9343 1757 5’ half) to yel-
low (BF9343 1760 3’ half). Inversions between IR-B, C and
D, would each change the 3′ module of the gene in the ex-
pression locus. Figure 1B (i), represents the orientation as
present in the published B. fragilis NCTC 9343 genome se-
quence. From this position, in order for the yellow-pink
module (BF9343 1760-1758 ) to be present at the expres-
sion locus, three inversion events are required. First, the
IR-A inversion, then the IR-B, and lastly, the IR-C inver-
sion (Figure 1B). This region thus potentially encodes eight
different combinations of specificity proteins, depending on
the orientation of the DNA (Figure 1C, Supplementary Fig-
ure S1). To determine whether each of the six specificity
subunit genes are present at the expression locus within a
population of in vitro grown bacteria, we performed PCR.
The forward primer (F1) is located upstream of the invert-
ible regions, at the 3′-end of the methylase-encoding gene
BF9343 1756, while the reverse primers (R1–6), are located
at the end of each of the gene halves. Elongation time was
short in order to amplify only the gene present at the ex-
pression locus (Figure 1B, outlined in black). Hence, only
gel bands of ∼1200 and ∼500 bp are present. These anal-
yses revealed that within this in vitro grown population, all
specificity half-genes are detected at the expression site (Fig-
ure 1D), although the 1758 half-gene (pink in Figure 1B)
amplicon is in low abundance (Figure 1D, lane 3).
Analysis of specificity gene transcription from in vitro and in
vivo grown bacteria
We next sought to quantify the relative percent of cells
expressing each specificity gene combination to examine
whether certain combinations are more prevalent than oth-
ers. To do so, we attempted to generate a set of mutants
in which each of the eight gene combinations (Figure 1C)
would be locked in place by deleting all the other speci-
ficity genes. We were successful in creating mutants where
the BF9343 1757 5′ half-gene was locked in the expres-
sion locus with each of the four 3′ half-genes (Figure 2A).
We made numerous attempts to obtain mutants with the
BF9343 1760 5′ half-gene (yellow 5′ in Figure 1C) locked
in the expression locus in combination with any of the 3′
half-genes, but were unable to create these mutants by the
methods used. The four locked mutants we did obtain (Fig-
ure 2A) allowed us to compare the percent expression from
the WT to the locked mutants (100% expression). RT-qPCR
analysis of WT B. fragilis NCTC 9343 grown to OD600 ∼
0.7 in rich medium revealed unequal expression of each of
these four combinations. The 1757-59 half-gene pairing was
at >60% expression level compared to the locked-ON mu-
tant (Figure 2B). The 1757-57 and 1757-60 pairings were in
approximate abundance of 10% and 20% relative to their
locked-ON counterparts, respectively, and transcript of the
1757-58 specificity gene configuration was barely detectable,
a result predicted by the previous PCR analysis (Figure 1D).
To confirm these data, the entire specificity region was am-
plified by PCR from the in vitro grown population, and se-
quenced for quantitative analysis (Figure 2C). The results
were similar to the RT-qPCR data (Figure 2C). Unlike the
RT-qPCR analysis, this method also revealed the frequency
of the 1760 5′ half-gene at the expression locus. Less than
12% of the in vitro grown bacteria have the 1760 gene at
the expression locus with any of the four C-terminal genes
(Supplementary Figure S2a, summation of the four right-
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Figure 1. A phase-variable Type-I R-M system in B. fragilis. (A) Gene map of the region. hsdR – restriction enzyme; hsdM- methylase; The colored region
of BF9343 1757-60, represents the phase-variable inverting regions of hsdS (specificity genes). (B) Genetic regions showing the specificity genes. i-iv show
the different DNA inversions that can occur in this region between inverted repeats shown as dashed lines. Only the outlined gene is transcribed. (C) The
eight specificity gene combinations possible from the different DNA inversions. (D) EtBr-stained agarose gel of the amplicons detecting each of the six
specificity half genes in the expression locus. Each fragment was amplified using primer F1 paired with each of the six reverse primers.
specificity gene combinations present at the expression lo-
cus from the population of in vitro grown bacteria.
To determine whether the relative percentages of these
specificity gene combinations at the expression locus are
the same from in vivo isolated bacteria, we mono-colonized
six sets of two gnotobiotic mice with WT bacteria. Colonic
contents were harvested and the transcripts of each of the
four combinations were quantified by qRT-PCR (Figure
2D). Compared to their abundances from bacteria grown in
vitro, there was a significant increase in the fold-change ex-
pression levels of 1757-57 (P-value < 0.0001) and 1757-58
(P-value < 0.0001) (Figure 2E) (‘0’ means no fold change
from in vitro grown bacteria). There was no significant
change from the in vitro level of the 1757-59 combination
and the sequencing data also showed very similar results to
those of the RT-qPCR (Figure 2F). The 1757-60 transcript
was not detected in the in vivo sample, but showed a slight
decrease in the sequencing analysis. There was an increase
in the prevalence of the 1760 gene (5’ end) at the expression
locus compared to in vitro grown bacteria (Supplementary
Figure S2b), with approximately 22% of the population hav-
ing this half-gene at the expression locus (summation of the
four rightmost bars).
Lastly, we examined whether the percentage of the vari-
ous S-gene combinations from in vivo isolated bacteria re-
vert back to the percentages detected in vitro after in vitro
passage. Three stool samples from three mice of different
cages were passaged in vitro five times before qRT-PCR
analysis. The data showed that these combinations reverted
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Figure 2. RT-qPCR and sequencing analysis of four of the specificity gene transcripts from WT bacteria grown in vitro and in vivo (A) Diagram of the
deletions made to lock each specificity gene combination at the expression locus. (B, C) Relative percentages of each of the four specificity gene transcripts
with the 1757 5’ end (blue) from in vitro grown WT bacteria by RT-qPCR (B) or by sequencing (C). (D) Relative percentages of each of the four specificity
gene transcripts (with the 1757 5’ end) from stool of mice monocolonized with WT bacteria. (E) RT-qPCR fold-change of specificity gene expression from
bacteria isolated from in vivo stool compared to bacteria grown in vitro. (F) Abundance of each specificity gene at the expression locus in vitro compared
to in vivo by sequencing. (G) Fold-change expression of specificity genes from bacteria isolated from in vivo stool and passaged five times compared to
bacteria grown in vitro.
(Figure 2G, ‘0’ means no change compared to in vitro bac-
teria from stock).
In vitro and in vivo competition assays
The WT population showed an uneven distribution of
specificity gene expression both in vitro and in vivo. We
speculated that the mutants locked-ON for the specificity
genes that were up-regulated in vivo may have a competi-
tive advantage in the mammalian gut. Therefore, we con-
ducted a competition assay in vitro and in the mammalian
gut. A 1:1:1:1 ratio of each of the four mutants was mixed
and grown in rich medium or gavaged into gnotobiotic
mice (Figure 3A). In the in vitro assay, none of the mu-
tants demonstrated a competitive advantage over the others
(Figure 3B). For the mouse experiments, stool samples were
plated at two time points: 18 h after gavage (Figure 3C) and
10 days after gavage (Figure 3D) and analyzed to determine
the percentage of each mutant. Eighteen hours after gav-
age, there was a statistically significant difference in the per-
centages of the mutants in the stool, and this difference was
maintained at day 10. The 1757-58 mutant, which showed
the greatest upregulation in vivo compared to in vitro, had
a competitive advantage over the 1757-59 and 1757-60 mu-
tants (P-values 0.0029 and 0.006).
Methylation site analysis
To determine the DNA sequences that are recognized by
each specificity subunit combination and the methylated
base, the four mutants were sequenced using SMRT se-
quencing. Each of the four mutants derives the 5′ portion
of the specificity gene from 1757, thus all four mutants
recognize the same 5′ sequence, which we determined was
GAC. The 5′ GAC is followed by five or six Ns and the
3′ recognition site is variable between mutants and con-
tains either three or four bp for a total of 11–12 bp in-
cluding the intervening Ns (Table 1). The recognition site
of the 3′ BF9343 1759 protein is GRTY, therefore, four dif-
ferent tetranucleotide sites are recognized by this half pro-
tein (GATC, GATT, GGTC, and GGTT), with the methy-
lation occurring on the A of the complementary strand. The
recognition sites for the other 3′ half proteins are each a
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Figure 3. Competitive growth and colonization assay among the four locked-ON mutants (A) the percent of each of the four mutants in the initial
inoculum (B) percentages of each mutant after dilution of 1:15 and regrowth in vitro. (C) percentages of each mutant from the fecal samples of mice 18 h
post-gavage, (D) or after 10 days of competitive competition in gnotobiotic mice. Three sets of two mice were used for the competitive colonization assay
and are differentiated by colored circles. P-values that were calculated are marked as follows: *P-value <0.05, **P-value <0.005, ***P-value <0.0005,
****P-value < 0.0001.
half recognition sites with the exception of GRTY have 23 of
the nucleotides G or C. The number of methylation sites in
the B. fragilis NCTC 9343 genome for each of these speci-
ficity proteins ranges from 1408 to 1931, with a total of 6479
sites for all four specificity proteins of this R-M system. The
number of these four recognition sites in each gene or inter-
genic region for the entire genome of B. fragilis NCTC 9343
is shown in Supplementary Table S1.
Per kilobase, the number of sites in coding regions is
greater than in intergenic regions with 1.30 total sites/kb in
coding regions and 0.67 sites/kb in intergenic regions (Ta-
ble 1). This difference likely reflects the %GC in these recog-
nition sites and the lower %GC in intergenic regions com-
pared to coding regions. We found that tRNA genes contain
a disproportionate number of recognition sites per kilobase
with a total of 21 sites reflecting 3.8 sites/kb, which may
be due in part to the high GC content of the 73 annotated
tRNA genes (54.3 %GC, on average). (Table 1). As R-M
systems are used for bacterial defense to restrict incoming
DNA, we analyzed the number of sites found in DNA hor-
izontally acquired by B. fragilis NCTC 9343. To this end,
we analyzed three elements annotated as integrative con-
jugative elements and one region annotated as an integrated
phage. In these four combined regions, there are a total of
126 methylation sites, with a per kb average of 1.84, with
these regions collectively having a %GC content just slightly
greater than the overall genome (46.6% versus 43.2%).
RNA-Seq analyses from in vitro and in vivo grown WT and
specificity gene locked mutants
DNA methylation can have a profound effect on gene tran-
scription, both up-regulating and down-regulating tran-
script levels in bacteria (39–41). To study the potential tran-
scriptional effects of the different methylation patterns in
the locked mutants, we performed RNA-Seq analysis. We
analyzed biological duplicates of WT bacteria and all four
locked mutants from bacteria grown in vitro and from cecal
contents of monocolonized mice. Using DESeq2 (27) and
EdgeR (28), we identified 220 genes differentially expressed
(>2-fold, P-value < 0.05) in at least one of the four mutants
compared to WT for in vitro grown bacteria, including 136
and 84 genes upregulated and down-regulated in the mu-
tants, respectively (Supplementary Table S2). For bacteria
from the mouse cecum, 332 genes were differentially regu-
lated in at least one mutant compared to WT, with 236 genes
upregulated and 96 genes down-regulated. Under in vitro
conditions, mutant 1757-60 exhibited the greatest number






/nar/article/48/19/11040/5921289 by guest on 27 M
ay 2021
11048 Nucleic Acids Research, 2020, Vol. 48, No. 19
Table 1. Analysis of specific methylation sites in B. fragilis NCTC 9343 genomea
Configurationb BF9343 1757–1757 BF9343 1757–1758 BF9343 1757–1759c BF9343 1757–1760
Pattern (GACN6TCC) (GACN5CTG) (GACN5GRTY) (GACN6TGC) Totals
Unique sitesd 1931 (958, 973) 1408 (723, 685) 1636 (802, 820, 14) 1504 (776, 728) 6479
Coding genee 1776 (791, 985) 1306 (815, 491) 1513 (929, 572, 12) 1410 (885, 525) 6005
Intergenic 107 62 85 (total, 2
palindromic)
75 329
rRNA 18 (6, 12) 18 (6, 12) 12 (12, 0, 0) 6 (0, 6) 54
tRNA 5 (3, 2) 1 (0, 1) 15 (3, 12, 0) 0 (0, 0) 21
ncRNA 0 0 0 0 0
tmRNA 0 0 0 0 0
Pseudo genes 28 (13, 15) 23 (15, 8) 14 (6, 8, 0) 14 (9, 5) 79
Integrated phage 12 10 15 5 42
ICE 18 16 28 22 84
Total mapped sitesf 1934 (813, 1014, 107) 1410 (836, 512, 62) 1639 (956, 598, 14, 85) 1505 (894, 536, 75) 6488
coding gene per kb 0.381 0.281 0.325 0.303 1.290
Intergenic per kb 0.217 0.126 0.173 0.152 0.668
rRNA per kb 0.657 0.657 0.438 0.219 1.971
tRNA per kb 0.904 0.181 2.713 0.000 3.798
pseudo per kb 0.397 0.326 0.199 0.199 1.121
int. phage per kb 0.249 0.207 0.311 0.104 0.871
ICE per kb 0.208 0.185 0.324 0.255 0.972
aThe genome consists of a 5205140 bp chromosome (NC 003228.3) and a 36 560 bp plasmid (NC 006873.1).
bThe configuration is named based on which S subunit is active.
cNote that BF9343 1757-1759 methylation pattern can be palindromic.
dReported as total (forward strand, reverse strand, both strands [BF9343 1757-1759 only]).
eAll genes (CDS, RNA) and pseudo genes are reported as total (coding strand, non-coding strand, both strands [BF9343 1757-1759 only]).
fTotal sites mapped exceeds unique sites due to overlapping DNA. Reported as total (coding strand, non-coding strand, both strands [BF9343 1757-1759
only], intergenic).
der in vivo conditions, mutant 1757-59 displayed the great-
est number of both upregulated and down-regulated genes.
Figure 4 shows heat maps of the 50 most upregulated and
down-regulated genes for the composite four mutants un-
der each growth condition. Notable is the presence of cap-
sular polysaccharide biosynthesis loci, of which there are
many in the B. fragilis NCTC 9343 genome (1). Each of
these polysaccharide biosynthesis regions is organized as an
operon, and for seven of these regions, the promoter driv-
ing PS synthesis is contained between IRs and undergoes
inversion, leading to phase-variable expression of the oper-
ons (1).
Genetic and phenotypic analyses of specificity gene locked
mutants
The RNA-Seq data show that there is more polysaccharide
F (PSF) transcript in the 1757-59 mutant than WT bacteria
and more polysaccharide B (PSB) transcript from the 1757-
58 mutant than WT from in vitro grown bacteria. We sought
to determine if these increases might be due to a greater per-
centage of the population having these invertible promot-
ers in the ON orientation. We performed a PCR-digestion
analysis of all seven invertible polysaccharide promoters in
WT and all four mutants to quantify the percentage of bac-
teria with each promoter in the ON and OFF orientation.
We show that the increases in transcripts correlate with the
ON/OFF orientations of the relevant PS promoters in these
two mutants (1757-58 and 1757-59). (Figure 5A). In addi-
tion, the PSE transcript was down-regulated relative to WT
in the 1757-60 mutant and this also correlated with most of
the PSE promoter being in the OFF orientation in this mu-
tant. The only promoter orientation that was distinct from
that of WT that did not correlate with differential transcript
levels was the PSE promoter in the 1757-57 mutant, which
was in the ON orientation in the vast majority of these bac-
teria. However, we previously showed that PSE transcrip-
tion is terminated downstream of the promoter when the
PSA locus is transcribed by the action of UpaZ (42), and
therefore, this PSE phenotype is as expected based on this
second level of regulation. These collective data show that
the increases and decreases in polysaccharide transcription
in these mutants occurs in most cases at the level of pro-
moter orientation.
To determine if the RNA-Seq data and the promoter
orientations are predictive of phenotype, we chose to an-
alyze synthesis of PSB using an antiserum to this capsular
polysaccharide (1). By the EdgeR analysis, the expression of
genes in the PSB biosynthesis locus are upregulated 4.41–
7.91-fold in the 1757-58 mutant compared to WT from in
vitro grown bacteria. Indeed, PSB was present on the sur-
face in 60% of the population from this mutant compared
to WT (9 or 16%), quantified both by imaging (immunoluo-
rescence, Figure 5B) and by flow-cytometry (Figure 5C, D).
Restoration of the full complement of specificity genes with
the upstream methylase gene transcribed from a plasmid-
borne promoter revealed a reversal of this phenotype, which
did not occur when the plasmid was added alone. In ad-
dition, when an expression plasmid containing the single
locked 1757-58 specificity gene was added to WT, it failed
to reproduce the PSB phenotype of the mutant (Figure 5C,
D). Therefore, this phenotype may be dependent on methy-
lation only at 1757-58 sites with methylation at other sites
precluding the phenotype.
Identification of hundreds of putative phase-variable Type I
R-M systems in diverse Bacteroidetes species
Bacteroidetes is a diverse phylum containing not only
species that are members of mammalian associated micro-
bial communities such as the gut, oral cavity, vagina and
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Figure 4. Heatmap of differentially regulated genes in the locked-ON mutants compared to WT. The top 100 (84 in the case of in vitro down) differentially
regulated genes (minimum 2-fold change, P-value ≤0.05 by both DESeq and EdgeR) for each of the four locked-ON mutants under both in vivo and in
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Figure 5. Phenotypic validation of RNA-Seq analysis. (A) Quantification of relative promoter orientations for the seven invertible PS promoters from each
population, (WT, and each locked-ON mutant), using PCR-digestion. Each assay results in four bands, two corresponding to the ON orientation and two
to the OFF orientation. (B) Immunofluorescence of bacteria using an antibody to PSB from WT and locked 1757-58. Percentage of labeled bacteria is
shown in the bottom right (600 X magnification). (C) percentage of PSB-positive cells by FACS for each of four mutants and the WT. All strains contained
either the vector control or the vector with the relevant specificity gene(s). p1757-58 contains the methylase gene and 1757-58 and pWT contains the entire
WT locus 1756 through 1760 behind a constitutive promoter. (D) Flow cytometry histograms of WT, and 1757-58, with either vector control or p1757-58
and pWT, respectively.
trial ecosystems. To determine how prevalent these phase-
variable R-M systems are among the members of this phy-
lum, we searched the genomes of 3528 Bacteroidetes. The
search was performed by querying the genomes for genes
encoding proteins with the Type I R-M DNA specificity do-
main model embodied by PFam (PF01420.18). Based on
these systems having full length genes next to half-genes
that can recombine into the expression locus, we searched
for regions with at least two specificity genes <10 kb apart
and for which one had to be 60% or less the size of any
of the other S-genes. These search criteria identified 1399
distinct loci present in 686 different genomes, which were
of 152 different species and 79 different genera of the Bac-
teroidetes phylum (Supplementary Table S3). In most cases,
the S-genes are adjacent and, in many genomes, there were
more than two adjacent S-genes, similar to this Type I R-M
system in B. fragilis NCTC 9343. This broad and prevalent
distribution of these putative phase-variable Type I R-M
systems in diverse species of very different ecosystems sug-
gests that they are biologically relevant to these organisms.
Phase-variation by DNA inversion of Type I R-M systems
may be another conserved property of this phylum of bac-
teria that contributes to the ability of these organisms to
adapt to changing conditions or threats in their ecosystems.
DISCUSSION
Here we show that a Type I R-M system of B. fragilis is
able to extensively diversify its methylation targeting so that
within a population of bacteria, eight different sites are
methylated, one per bacterial cell. The property of phase
varying the synthesis of numerous molecules in the gut Bac-
teroidales has long been predicted to be a bet-hedging strat-
egy to ensure survival of a strain by creating diversity in the
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Type I R-M systems throughout the Bacteroidetes phylum
suggests a fitness benefit to these diverse host-associated
and environmental organisms in the complex microbial
communities in which they must adapt and compete under
changing environmental conditions.
Phase-variable Type I R-M systems with shuffling target
domain genes were first described in Mycoplasma pulmo-
nis (43) and have since been described in other bacteria (re-
viewed (44)). In addition to contributing to the protection
of a bacterial population from phage infection (16,45), these
phase-variable systems have also been shown to affect other
phenotypes due to differing epigenetic states within a bac-
terial population. Manso et al. showed that locked speci-
ficity gene mutants in Streptococcus pneumoniae had dif-
fering virulence capabilities in a mouse model of infection
(18) , and this difference could be attributed to differential
expression of the capsule operon. We similarly found here
that the capsular polysaccharide biosynthesis genes were
among the most differentially regulated in the specificity
gene locked mutants relative to WT. These phenotypes cor-
related with orientation of the invertible promoters of these
polysaccharide biosynthesis regions. Analysis of these pro-
moter regions for the presence of methylation sites that may
affect their inversions did not reveal any candidate sites. In-
deed, in S. pneumoniae, the epigenetic change leading to dif-
ferential expression of the capsule genes is still not under-
stood. Due to the global nature of the epigenetic changes in
these locked specificity gene mutants, the regulation may be
multifactorial. Nevertheless, by complementary phenotypic
analyses, we confirmed that PSB is synthesized in a greater
percentage of the population of the 1757-58 locked mutant
compared to WT, correlating with the transcriptomics data.
Another phenotypic difference between the specificity genes
mutants was in their ability to compete for colonization of
the gnotobiotic mouse gut. After just 10 days of coloniza-
tion, there was a significant difference in their proportions
in the stool. We similarly found that the proportions of the
specificity gene combinations in the expression locus varies
depending on the environment (in vitro versus in vivo). In-
deed, in vivo isolated bacteria return to the in vitro specificity
gene proportions if subsequently passaged in vitro.
DNA inversions in Bacteroides are typically mediated
by tyrosine site-specific recombinases that act locally on
nearby inverted repeats. One gene upstream of the Type
I R-M locus (BF9343 1751) and two downstream genes
(BF9343 1761 and BF9343 1763) encode putative tyrosine
type site-specific recombinases. It is likely that all or some
of these act to mediate inversions in this region. As there
are four different IRs in this regions that are not similar to
each other, it is possible that there is at least one additional
site-specific recombinase that may also be involved.
A remaining unanswered question is how can an inver-
sion of the specificity region occur with subsequent al-
teration of the methylation/ restriction site, without self-
restriction. In the organism studied here, the genome en-
codes an ArdA anti-restriction protein, which specifically
inhibits the action of restriction enzymes of Type I RM sys-
tems (46), allowing only the modification enzyme to func-
tion. Therefore, in this strain, the main function of this sys-
tem is DNA methylation. This ardA gene, BF9343 1161, is
contained on an integrative and conjugative element as is
typical of ardA genes (47), and therefore, this function could
be conjugally transferred to similar strains and species
within an ecosystem. Of the 686 Bacteroidetes genomes
identified as likely having phase-variable Type I RM sys-
tems (Supplementary Table S3), 224 also have a gene en-
coding a protein with the ArdA pfam PF07275.12. There-
fore, in these strains, it is likely that the main function of
these Type I RM systems is for phase-variable methylation,
possibly modulating phenotypes in these organisms.
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